FWP - Forward Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue-25,000--
Gross Profit--25,000--
Operating Expenses
Research Development2,74812,58841,05233,727
Selling General and Administrative9,08218,74814,06715,852
Non Recurring----
Total Operating Expenses11,83056,33655,11949,579
Operating Income or Loss-11,830-56,336-55,119-49,579
Income from Continuing Operations
Total Other Income/Expenses Net2,9041,240,82458012,239
Earnings Before Interest and Taxes-11,830-56,336-55,119-49,579
Interest Expense----
Income Before Tax-8,9261,184,488-54,539-37,340
Income Tax Expense-204267,395-21,203-336
Minority Interest----
Net Income From Continuing Ops-8,722917,093-33,336-37,004
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,722917,093-33,336-37,004
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,722917,093-33,336-37,004